Price10-week line30-week trend line252 trading days
Relative strength vs the F&O universe RS line· baseline 100
The RS line is below its peak and not rising — this stock isn’t out-leading the universe right now, whatever its price is doing.
Returns
3M
-21.5%
6M
-6.0%
9M
-15.3%
12M
-21.0%
52-week range
₹765₹1098
-30.3% from its 52-week high
Trend-health checklist0/5
✕Price above the 30-week line
✕30-week line is rising
✕10-week line above the 30-week line
✕Price above the 10-week line
✕Strength rank 70 or higher
Extension & risk
Above 30-week line
-16.7%
Below the line
30-week line (floor)
₹918
structural floor
Risk back to floor
20.1%
if it returns there
10-week line
₹909
nearer support
If price slid back to its 30-week line from here, that is 20.1% — the structural risk this far above the line. These are levels read from the price series, not a buy or sell call.
Futures positioning
Short buildupcurrent-month future · 27 days to expiry
Short buildup: futures price down and open interest up — fresh short positions being opened. The textbook bearish-leaning futures read.
Basis (future vs cash)
+0.20%
premium · ₹1.6
Open interest
+8.7%
vs prior session
Future price
₹767
cash ₹765
Futures move
-7.8%
today
Read from the current-month futures contract. Around monthly expiry these reads turn noisy as positions roll to the next series. Descriptive of positioning, not a buy or sell call.
Options positioning
current-month option chain · 31 strikes near the money · 27 days to expiry
ATM implied volatility
30.1%
call 30% · put 30%
Expected move to expiry
±8.2%
~ ±₹63 (1SD)
Put/call ratio (OI)
0.84
by volume 1.68
Max pain
₹800
ATM ₹770
Read from the current-month option strikes around the money. Implied volatility is solved from the at-the-money call and put; the expected move is the one-standard-deviation range those prices imply to expiry. Near expiry these compress as time value decays. Descriptive of option pricing, not a buy or sell call.
The 30-week line is computed live from adjusted prices; the checklist is computed from that same series, so chart and score always agree. Educational analysis only — not a recommendation, and not investment advice.